Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/12 → 3/31/15 |
Funding
- Pluristem Therapeutics Incorporated: $8,969.00
Pluristem - A Phase 2, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects with Intermitte
- Saha, Sibu (PI)
- Ferraris, Victor (CoI)
- Minion, David (CoI)
- Sorial, Ehab (CoI)
- Xenos, Eleftherios (CoI)